Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats

T. Yamada, K. Nakao, H. Itoh, G. Shirakami, K. Kangawa, N. Minamino, H. Matsuo, H. Imura

Research output: Contribution to journalArticle

52 Citations (Scopus)


The effect of intracerebroventricular (i.c.v.) injection of brain natriuretic peptide (BNP), a novel peptide purified from the porcine brain, on arginine vasopressin (AVP) secretion was studied in conscious, unrestrained rats and was compared with that of atrial natriuretic polypeptide (ANP). I.c.v. administration of BNP (0.01, 0.1 or 1 nmol) significantly inhibited basal AVP secretion and the effect of BNP was comparable to that of ANP. The AVP secretion induced by i.c.v. injection of angiotensin II (0.1 nmol) was significantly suppressed by the pretreatment with BNP (0.1 or 1 nmol). These results suggest that BNP is involved in the central control of AVP secretion either alone or in combination with brain ANP.

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalNeuroscience Letters
Issue number1-3
Publication statusPublished - 1988 Dec 19



  • Angiotensin II
  • Arginine vasopressin
  • Atrial natriuretic polypeptide
  • Brain natriuretic peptide

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this